Helicobacter pylori - Related Immunoglobulins in Sarcoidosis

Journal of Investigative Medicine

Volumn 52, Issue 2, 2004, Pages 137-143

  Herndon, Betty L ^a   Vlach, Victoria ^a   Dew, Michelle ^a   Willsie, Sandra K ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Helicobacter pylori; Immunoglobulin G; Sarcoidosis; Serum antibody titer; Urease

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; UREASE; CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LUNG SARCOIDOSIS; MALE; SERUM; UNITED STATES; COMPARATIVE STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL SYMPTOM; LUNG FUNCTION TEST; MIDDLE AGED; NONHUMAN;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 1642329908     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-52-02-23     Document Type: Article

References (31)

1. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (NASOG). Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-55.
2. Jones CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine 1999;78:65-111.
3. Papadopoulos KI, Sjoberg K, Lindgren S, et al. Evidence of gastrointestinal immune reactivity in patients with sarcoidosis. J Intern Med 1999;245:525-31.
4. Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 2000;12:71-6.
5. Agostini C, Facco M, Chilosi M, et al. Alveolar macrophage-T cell interactions during Th 1 type sarcoid inflammation. Microsc Res Tech 2001;53:278-87.
6. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2000;18 Suppl 32:56s-68s.
7. Capelli A, DiStefano A, Lusuardi M, et al. Increased macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta levels in BAL of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002;165:236-41.
8. Shigehara K, Shijubo N, Ohmichi M, et al. Enhanced mRNA expression of Th 1 cytokines and IL- 2 in active pulmonary sarcoidosis. Sarcoidosis Vascul Diffuse Lung Dis 2000;17:151-7.
9. Inui N, Chida K, Suda T, Nakamura H. Th1/Th2 and Tc1/Tc2 profiles in peripheral blood and BAL fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 2001;107:337-44.
10. Shigehara K, Shijubo N, Ohmichi M, et al. IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs. J Immunol 2001;166:642-9.
11. Seitzer U, Gerdes J, Muller-Quernheim J. Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res 2002;3:6.
12. Muller-Quernheim J. Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoid Vascul Diffuse Lung Dis 1998;15:22-37.
13. Maeda H, Niimi T, Sato S, et al. Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients. Chest 2000;118:923-7.
14. Johnson LA, Edsall JR, Austin JHM, et al. Pulmonary sarcoidosis: could Mycoplasma-like organisms be a cause? Sarcoidosis Vascul Diffuse Lung Dis 1996;13:38-42.
15. Fukuda T, Sato K, Tachikawa S, et al. Mucosa-associated lymphoid tissue lymphoma coexisting with epithelioid granulomas in the stomach of a patient with systemic sarcoidosis. Pathol Int 1997;47:870-5.
16. Voderholzer WA, Zeitz C, Feucht HE, et al. Gastric outlet obstruction and pulmonary infiltrate in a patient with Crohn's disease. Z Gastroenterol 2000;38:637-41.
17. Thomas MJ, Noble A, Sawicka E, et al. CD8 T cells inhibit IgE via dendritic cell IL-2 induction that promotes Th 1 T cell counter-regulation. J Immunol 2002;168:216-23.
18. Heyman B, Tianmin L, Gustavsson S. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur J Immunol 1993;23:1739-42.
19. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
20. Crapo RO, Morris AH, Clayton PD, et al. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982;18:419-23.
21. Moore RA Helicobacter pylori and peptic ulcer, a systematic review of effectiveness. Pain Research, Churchill Hospital, Headington, Oxford, 1994. Available at: http://www.jr2.ox. ac.uk/bandolier/bandopubs/hpgL/hpall.html (accessed Nov 13, 2003).
22. Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998;26:60-3.
23. Hunninghake GW, Crystal RG. Mechanism of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest 1981;67:86-92.
24. Rankin JA. Naegel GP, Schrader CE, et al. Air-space immunoglobulin production and levels in bronchoalveolar lavage fluid of normal subjects and patients with sarcoidosis. Am Rev Respir Dis 1983;127:442-8.
25. Torres J, Camorlinga-Ponce M, Perez-Perez G, et al. Specific serum IgG response to urease and Cag A antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin Diagn Lab Immunol 2002;9:97-100.
26. Moller DR. Etiology of sarcoidosis. Clin Chest Med 1997;18:695-706.
27. Barnard J, Newman LS. Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol 2001;13:84-91.
28. Wahlstrom J, Berlin M, Skold CM, et al. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and BAL fluid from patients with pulmonary sarcoidosis. Thorax 1999;54:339-46.
29. Lehmann C, Wilkening A, Leiber D, et al. Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes and subsequently rejoin the systemic immune system. Anat Rec 2001;264:229-36.
30. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344:665-71.
31. Cassell GH. Infectious causes of chronic inflammatory diseases and cancer. Emerg Infect Dis 1998;4:1-17.